SCHEMBL7656172

SCHEMBL7656172

O=C(O)c1ccc2c(c1)C(=O)NS2(=O)=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 1/20 0.57
DAPK3 O43293 1/20 0.57
MAP4K4 O95819 1/20 0.57
RET P07949 1/20 0.57
PIM1 P11309 1/20 0.57
LTK P29376 1/20 0.57
GRK5 P34947 1/20 0.57
CSNK1A1 P48729 1/20 0.57
CDK8 P49336 1/20 0.57
PRKX P51817 1/20 0.57
LIMK1 P53667 1/20 0.57
CDK5 Q00535 1/20 0.57
ACVR1 Q04771 1/20 0.57
PTK2 Q05397 1/20 0.57
TYRO3 Q06418 1/20 0.57
PRKAA1 Q13131 1/20 0.57
DYRK1A Q13627 1/20 0.57
NTRK3 Q16288 1/20 0.57
LRRK2 Q5S007 1/20 0.57
CLK4 Q9HAZ1 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29643009 0.88 CA12 (0.59) CHEK1DAPK3MAP4K4RETPIM1
SCHEMBL3399246 0.88 CA12 (0.59) CHEK1DAPK3MAP4K4RETPIM1
SCHEMBL28432702 0.85 CHEK1 (0.56) CHEK1DAPK3MAP4K4RETPIM1
SCHEMBL7651801 0.85 CHEK1 (0.60) CHEK1DAPK3MAP4K4RETPIM1
Saccharin SCHEMBL27832154 0.78 CA12 (0.73) CHEK1DAPK3MAP4K4RETPIM1
Saccharin SCHEMBL27518097 0.78 CA12 (0.73) CHEK1DAPK3MAP4K4RETPIM1
Saccharin SCHEMBL28246972 0.78 CA12 (0.73) CHEK1DAPK3MAP4K4RETPIM1
Saccharin SCHEMBL29270979 0.78 CA12 (0.67) CHEK1CA12CA9CA2CA1
Saccharin SCHEMBL27496305 0.76 CA12 (0.65) CHEK1CA12CA9CA2CA1
Saccharin SCHEMBL28045129 0.76 CA12 (0.92) CHEK1DAPK3MAP4K4RETPIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240065302-A1 SWEETENER COMPOSITIONS COMPRISING MOGROSIDES AND USES THEREOF FIRMENICH INCORPORATED 2024-02-29 US disclosed
WO-2023111350-A2 CARBONIC ANHYDRASE IX LIGANDS 3B PHARMACEUTICALS GMBH (DE) 2023-06-22 WO disclosed
US-20180086751-A1 SWEETENER COMPOSITION SENOMYX, INC. 2018-03-29 US disclosed
US-9603848-B2 Modulation of chemosensory receptors and ligands associated therewith SENOMYX, INC. (US) 2017-03-28 US disclosed
EP-2062050-B1 MODULATION OF CHEMOSENSORY RECEPTORS AND LIGANDS ASSOCIATED THEREWITH SENOMYX INC (US) 2016-05-18 EP disclosed
US-9181276-B2 Modulation of chemosensory receptors and ligands associated therewith SENOMYX, INC. (US) 2015-11-10 US disclosed
US-9181276-B2 Modulation of chemosensory receptors and ligands associated therewith SENOMYX, INC. (US) 2015-11-10 US disclosed
US-20140235623-A1 MODULATION OF CHEMOSENSORY RECEPTORS AND LIGANDS ASSOCIATED THEREWITH SENOMYX, INC. (US) 2014-08-21 US disclosed
US-20140235623-A1 MODULATION OF CHEMOSENSORY RECEPTORS AND LIGANDS ASSOCIATED THEREWITH SENOMYX, INC. (US) 2014-08-21 US disclosed
US-8633186-B2 Modulation of chemosensory receptors and ligands associated therewith SENOMYX INC. (US) 2014-01-21 US disclosed
US-8633186-B2 Modulation of chemosensory receptors and ligands associated therewith SENOMYX INC. (US) 2014-01-21 US disclosed
US-8541421-B2 Methods of enhancing sweet taste of compositions using substituted thieno{2,3-D}pyrimidines SENOMYX INC. (US) 2013-09-24 US disclosed
EP-2568287-A2 Modulation of chemosensory receptors and ligands associated Senomyx, Inc. (US) 2013-03-13 EP disclosed
US-20110224155-A1 MODULATION OF CHEMOSENSORY RECEPTORS AND LIGANDS ASSOCIATED THEREWITH SENOMYX INC. (US) 2011-09-15 US disclosed
US-20110224155-A1 MODULATION OF CHEMOSENSORY RECEPTORS AND LIGANDS ASSOCIATED THEREWITH SENOMYX INC. (US) 2011-09-15 US disclosed
US-6410485-B1 AGRICULTURE; CONTROLLING WEEDS BASF AKTIENGESELLSCHAFT (DE) 2002-06-25 US disclosed
US-6083880-A Saccharine-5-carbonyl-cyclohexane-1, 3, 5-trione derivatives, their preparation and their use as herbicides BASF AKTIENGESELLSCHAFT (DE) 2000-07-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140235623-A1 MODULATION OF CHEMOSENSORY RECEPTORS AND LIGANDS ASSOCIATED THEREWITH TAS2R30, TAS2R50, TAS2R1 CHEK1 3261/4885DAPK3 1784/4885MAP4K4 2834/4885
US-20180086751-A1 SWEETENER COMPOSITION TAS2R50, TAS1R2, TAS2R10 CHEK1 2119/4885DAPK3 4534/4885MAP4K4 4109/4885
US-20110224155-A1 MODULATION OF CHEMOSENSORY RECEPTORS AND LIGANDS ASSOCIATED THEREWITH TAS2R30, TAS2R50, TAS2R1 CHEK1 3261/4885DAPK3 1784/4885MAP4K4 2834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.